Enhancement of human immunodeficiency virus (HIV)-specific CD4+ and CD8+ cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine.
about
Pathogenesis of human immunodeficiency virus infectionCD4(+) T cells and gamma interferon in the long-term control of persistent friend retrovirus infection.HIV immunotherapeutic vaccines.Safety and immunogenicity of ALVAC vCP1452 and recombinant gp160 in newly human immunodeficiency virus type 1-infected patients treated with prolonged highly active antiretroviral therapyTherapeutic immunization strategies for the control of HIV-1.Direct injection of a recombinant retroviral vector induces human immunodeficiency virus-specific immune responses in mice and nonhuman primatesEvaluation of human immunodeficiency virus type 1 (HIV-1)-specific cytotoxic T-lymphocyte responses utilizing B-lymphoblastoid cell lines transduced with the CD4 gene and infected with HIV-1.A novel HIV T helper epitope-based vaccine elicits cytokine-secreting HIV-specific CD4+ T cells in a Phase I clinical trial in HIV-uninfected adults.Contact of human immunodeficiency virus type 1-infected and uninfected CD4+ T lymphocytes is highly cytolytic for both cells
P2860
Q24634681-094CA515-D8E6-45AA-A88C-7DE818705246Q33834466-F1EE5E75-30F7-47E5-8417-7F4F31AEF7B2Q34121204-D9BF0F93-086E-4C1A-84B8-294BD4CD556FQ34332119-7C08CFA2-431D-4D62-9C4F-471E02454E2AQ36238709-47D4073A-5CAA-47AF-BB00-B3692C4DC63FQ36624976-3B7A5916-10CE-45BF-9842-D7821191269AQ36625106-D04B16C3-7B37-4A68-9B54-A9AE2804A456Q37442415-E21FFDDF-5788-42C2-B76E-92DF076145B0Q39872348-F86510E4-4923-400F-A55F-E8ACEE15D6E2
P2860
Enhancement of human immunodeficiency virus (HIV)-specific CD4+ and CD8+ cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 1992
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Enhancement of human immunodef ...... ven recombinant gp160 vaccine.
@en
Enhancement of human immunodeficiency virus
@nl
type
label
Enhancement of human immunodef ...... ven recombinant gp160 vaccine.
@en
Enhancement of human immunodeficiency virus
@nl
prefLabel
Enhancement of human immunodef ...... ven recombinant gp160 vaccine.
@en
Enhancement of human immunodeficiency virus
@nl
P2093
P2860
P356
P1476
Enhancement of human immunodef ...... ven recombinant gp160 vaccine.
@en
P2093
D Katzenstein
T C Merigan
P2860
P304
11204-11208
P356
10.1073/PNAS.89.23.11204
P407
P577
1992-12-01T00:00:00Z